Patent ID: 7723050
Filing Date: 2010-05-25
Classification: G01N,G16H,Y02A

Abstract:
1. A method of evaluating risk for developing a diabetic condition, the method comprising: (a) obtaining from at least one biological sample isolated from an individual measurements of biomarkers comprising the biomarkers ADIPOQ (Adiponectin), GLUCOSE and CRP (C-Reactive Protein), and further comprising at least one biomarker selected from the group consisting of HBA1C (Glycosylated Hemoglobin), IGFBP1 (Insulin-like growth factor binding protein 1), IGFBP2 (Insulin-like growth factor binding protein 2), Insulin, LEP (Leptin) and TRIG (Triglycerides); (b) calculating a risk for developing a diabetic condition from the output of a model, wherein the inputs to said model comprise said measurements, and further wherein said model was developed by fitting data from a longitudinal study of a selected population of individuals and said fitted data comprises levels of said biomarkers and conversion to Diabetes in said selected population of individuals; and (c) reporting said calculated risk to a reporting means comprising a visual display or a printer.